ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
March 19, 2024 08:07 ET
|
ClearPoint Neuro, Inc.
ClearPoint Neuro's partner's completed BLA Submission for Upstaza™ would be first disease-modifying treatment for AADC Deficiency in the US.
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
March 19, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024
March 19, 2024 08:00 ET
|
Ludwig Enterprises, Inc.
SPARKS, Nev., March 19, 2024 (GLOBE NEWSWIRE) -- Ludwig Enterprises, Inc, (OTC: LUDG): A US-based biotechnology company is pleased to announce it has entered the booming artificial intelligence...
Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance
March 19, 2024 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer...
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations
March 19, 2024 08:00 ET
|
MedBright AI Investments Inc.
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) -- The European Academy of Allergy and Clinical...
在巴伦西亚, 西班牙举行的 2024 年欧洲变态反应与临床免疫学学会大会上报道变态反应和临床免疫学的最新发展动态
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 巴伦西亚, 西班牙, March 19, 2024 (GLOBE NEWSWIRE) -- 欧洲变态反应与临床免疫学学会 (EAACI) 拥有来自 125 个国家/地区的 16,000...
報導於西班牙華倫西亞舉行的 EAACI Congress 2024(2024 年度歐洲過敏及臨床免疫學會大會)中,過敏症及臨床免疫學的最新動態
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 華倫西亞,西班牙, March 19, 2024 (GLOBE NEWSWIRE) -- 來自全球 125 個國家及地區,會員人數逾 16,000 人的 European Academy of Allergy...
Couvrez les derniers développements en matière d'allergie et d'immunologie clinique lors du Congrès 2024 de l'EAACI à Valence en Espagne
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCE, Espagne, 19 mars 2024 (GLOBE NEWSWIRE) -- L'European Academy of Allergy and Clinical Immunology...
Informieren Sie sich über die neuesten Entwicklungen auf dem Gebiet der Allergie und klinischen Immunologie auf dem EAACI-Kongress 2024 in Valencia, Spanien
March 19, 2024 07:42 ET
|
European Academy of Allergy and Clinical Immunology
http://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294 VALENCIA, Spanien, March 19, 2024 (GLOBE NEWSWIRE) -- Die Europäische Akademie für Allergologie und...